|
|
Internal Medicine Comprehensive Review and Update 2025 - LIVE STREAMING
Comprehensive, Evidence-Based Updates for Internal Medicine and Its Subspecialties
This program, the 65th annual Internal Medicine Update from the leading clinical faculty of Harvard Medical School and Massachusetts General Hospital, provides comprehensive, high-yield instruction to ensure clinicians are current with the latest evidence and best practices to optimize patient care.
This program covers the breadth of Internal Medicine subspecialties, including:
• Cardiovascular Medicine... |
|
|
Making The Call in Lower-Risk MDS Exploring Treatments That Improve Outcomes & Decrease Transfusion Burden
Myelodysplastic syndromes (MDSs) are among the most common hematologic malignancies and are characterized by their risk of progression to acute leukemia. Although patients with lower-risk MDS (LR-MDS) have longer life expectancies compared to those with high-risk disease, their disease course is not without challenges. In fact, symptoms related to anemia are very common in this population and lead to poor quality of life. Fortunately, therapies are now available to treat the anemia associated ... |
|
|
Management of Cancer Pain: Current Guidelines
STATEMENT OF NEED
Patients with cancer often suffer from a range of symptoms that negatively impact their quality of life. Among the most significant of these symptoms is pain, which can be caused by surgery, radiation, chemotherapy, targeted therapy, diagnostic procedures, and/or supportive care measures. Between 20% and 50% of patients with cancer experience pain, including moderate-to-severe pain in approximately 80% of patients with advanced-stage cancer (NCI, 2023). Despite awareness a... |
|
|
Management of Venous Thromboembolism in Hospitalized Patients With Cancer
STATEMENT OF NEED
Venous thromboembolism (VTE) is a common and potentially deadly complication in patients with cancer, and hospitalized cancer patients are at an increased risk for both first-time and recurrent VTE. The National Comprehensive Cancer Network (NCCN) recommends VTE prophylaxis for all hospitalized cancer patients. Therefore, it is crucial for oncology nurses to be aware of risk factors, prevention, signs and symptoms, diagnosis, and management of VTE. This activity will discu... |
|
|
Management of Venous Thromboembolism in Hospitalized Patients With Cancer
TATEMENT OF NEED
Venous thromboembolism (VTE) is a common and potentially deadly complication in patients with cancer, and hospitalized cancer patients are at an increased risk for both first-time and recurrent VTE. The National Comprehensive Cancer Network (NCCN) recommends VTE prophylaxis for all hospitalized cancer patients. Therefore, it is crucial for oncology nurses to be aware of risk factors, prevention, signs and symptoms, diagnosis, and management of VTE. This activity will discuss ... |
|
|
Cancer Treatment Related Cognitive Impairment - Connie Carson, PhD, CCC-SLP
Oncology professionals, nurses, neuropsychologists, and psychologists have established cancer treatment related cognitive impairment (CTRCI) as a common side-effect of cancer treatment, impacting as many as 75% of cancer survivors; yet, speech-language pathologists have been silent in establishing their role in the treatment of this phenomenon. This presentation will provide the necessary background for them to be able to do so. Clinical symptoms will be defined and therapeutic suggestions off... |
|